100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond
London Global Cancer Week 2026 Speakers
Harvey Pekar: Lymphoma, Art, and Our Cancer Year
Mark Lawler: Ireland Introduces Five-Year Right to Be Forgotten Period for Cancer Survivors
Cris Bergerot: How Can Patient-Reported Symptoms Improve TKI Adherence?
Bishal Gyawali: Recommendations for Improved Toxicity Reporting in Clinical Trials
ESMO 2026: 10 ADCs in Lung Cancer to Watch
Shrenik Shah: A Diagnosis May Change Someone's Life, but it Doesn't Define Their Whole Story
OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.
